The concomitant of non-classical stereotactic body radiotherapy with tislelizumab based on multidisciplinary modalities for leiomyosarcoma: A case report
In this clinical case, we have observed that the OSB technique, which employs an increased per-fraction radiotherapy dose without the need to match the single-fraction doses typical of conventional SBRT, effectively enhances the therapeutic impact on leiomyosarcoma without an increase in radiotherapy-related side effects. By integrating the OSB technique with a multidisciplinary array of antineoplastic strategies, we can more effectively manage sarcomas in clinical practice.
Authors
- Xiaona Han
- Yaru Lin (ORCID: https://orcid.org/0009-0007-0506-5566)
- Lan Yu (ORCID: https://orcid.org/0000-0002-2748-3853)
- Yanhao Liu (ORCID: https://orcid.org/0000-0001-6701-3031)
- Xiaotao Zhang (ORCID: https://orcid.org/0000-0001-7213-4970)
- Wenxue Tong (ORCID: https://orcid.org/0000-0003-3462-2740)
- Jinying Li (ORCID: https://orcid.org/0000-0003-1362-1757)
- Xiao Li (ORCID: https://orcid.org/0000-0002-5531-1426)
- Li Liu (ORCID: https://orcid.org/0000-0001-8512-8676)
- Xi Cheng (ORCID: https://orcid.org/0000-0002-0838-5094)
Institutions
- Qingdao University (CN)
- BeiGene (China) (CN)
- Affiliated Hospital of Qingdao University (CN)
- S.P.E.C.I.E.S. (US)
Publication Details
- Journal
- Medicine
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1097/md.0000000000040278
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00